Company Harpoon Therapeutics, Inc.
Equities
HARP
US41358P2056
Biotechnology & Medical Research
Business Summary
Number of employees: 53
Managers
Managers | Title | Age | Since |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 18-10-10 |
Frank Lanza
DFI | Director of Finance/CFO | 62 | 19-03-31 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-31 |
Holger Wesche
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-09-30 |
Luke Walker
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-02 |
Haibo Wang
PRN | Corporate Officer/Principal | - | 23-07-31 |
Banmeet Anand
PRN | Corporate Officer/Principal | - | 22-07-05 |
Wendy Chang
HRO | Human Resources Officer | - | 22-07-05 |
Rachael Lester
PRN | Corporate Officer/Principal | - | 17-08-31 |
James B. Bucher
LAW | General Counsel | 59 | 12-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 18-10-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,397,205 | 16,465,638 ( 76.95 %) | 0 | 76.95 % |
Company contact information
Harpoon Therapeutics, Inc.
611 Gateway Boulevard Suite 400
94080, South San Francisco
+650 443 7400
http://www.harpoontx.comSector
1st Jan change | Capi. | |
---|---|---|
-2.39% | 103B | |
+1.87% | 95.28B | |
+1.69% | 22.15B | |
-15.30% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.12% | 16.05B | |
+4.20% | 13.68B | |
+35.72% | 12.17B |